Prognostic Value of Molecular Breast Cancer Subtypes based on Her2, ESR1, PGR and Ki67 mRNA-Expression in Muscle Invasive Bladder Cancer

Por Kriegmair, M.C., Wirtz, R.M., Worst, T.S., Breyer, J., Ritter, M., Keck, B., Boehmer, C., Otto, W., Eckstein, M., Weis, C.A., Hartmann, A., Bolenz, C., Erben, P.
Publicado no Transl Oncol (2018)

Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer

Por Ihnen, M, Wirtz, R M, Kalogeras, K T, Milde-Langosch, K, Schmidt, M, Witzel, I, Eleftheraki, A G, Papadimitriou, C, Jänicke, F, Briassoulis, E, Pectasides, D, Rody, A, Fountzilas, G, Müller, V
Publicado em 2010

Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: A Hellenic Cooperative Oncology Group (HeCOG) study

Por Koutras, A K, Kalogeras, K T, Dimopoulos, M-A, Wirtz, R M, Dafni, U, Briasoulis, E, Pectasides, D, Gogas, H, Christodoulou, C, Aravantinos, G, Zografos, G, Timotheadou, E, Papakostas, P, Linardou, H, Razis, E, Economopoulos, T, Kalofonos, H P, Fountzilas, G
Publicado em 2008